TITLE

The Diurnal Rhythm of the Cytoprotective Human Trefoil Protein TFF2 Is Reduced by Factors Associated with Gastric Mucosal Damage: Ageing, Helicobacter pylori Infection, and Sleep Deprivation

AUTHOR(S)
Johns, C. Emma; Newton, Julia L.; Westley, Bruce R.; May, Felicity E. B.
PUB. DATE
July 2005
SOURCE
American Journal of Gastroenterology;Jul2005, Vol. 100 Issue 7, p1491
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES : To determine if the normal TFF2 diurnal rhythm is disrupted in those with increased risk of gastric morbidity. Trefoil proteins protect the gastrointestinal mucosa from damage and aid its repair. TFF2 is considered the major cytoprotective gastric trefoil protein. There is a marked circadian variation in gastric luminal TFF2 in young healthy volunteers with peak levels present during the night. METHODS : Gastric juice was aspirated at two hourly intervals over a 24-h period via a nasogastric tube. TFF2 was measured by quantitative western transfer analysis. Helicobacter pylori ( H. pylori) status was measured by C13 urea breath test and by serology. The effects of H. pylori infection, sleep deprivation, and ageing, which cause increased gastric morbidity, on the TFF2 circadian rhythm were tested. RESULTS : H. pylori infection attenuated the increase in TFF2 that occurs during the night. The TFF2 diurnal rhythm was reduced in older people and both the TFF2 level reached and the time at which the maximum TFF2 concentration occurs were associated inversely with age ( p < 0.005). Sleep deprivation delayed the normal night time increase in gastric TFF2 and resulted in an overall reduction in TFF2 secretion. CONCLUSIONS : H. pylori infection, ageing, and sleep deprivation cause a reduction in the TFF2 diurnal rhythm. The demonstration that the TFF2 rhythm is impaired in cohorts of individuals known to suffer gastric symptoms suggests that interventions to restore the normal TFF2 rhythm in those with poor mucosal protection could reduce morbidity. (Am J Gastroenterol 2005;100;1491–1497)
ACCESSION #
17342111

 

Related Articles

  • Helicobacter pylori Infection in Skin Diseases: A Critical Appraisal. Wedi, B.; Kapp, A. // American Journal of Clinical Dermatology;2002, Vol. 3 Issue 4, p273 

    More than 50% of the human population have long-term Helicobacter pylori infection, causing, in some cases, severe diseases such as peptic ulcers and stomach cancer. In the last few years several extra-gastrointestinal disorders have been associated with H. pylori infection. This review...

  • Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study. Ang, Tiing Leong; Fock, Kwong Ming; Teo, Eng Kiong; Chan, Yiong Huak; Ng, Tay Meng; Chua, Tju Siang; Tan, Jessica Yi-Lyn // Journal of Gastroenterology;Jul2006, Vol. 41 Issue 7, p647 

    This randomized, double-blind study compared the efficacy of Helicobacter pylori eradication against prokinetics in H. pylori-infected functional dyspepsia patients. Patients with moderately severe or severe dyspepsia fulfilling the Rome II criteria were randomized to either H. pylori...

  • HELICOBACTER PYLORI INFECTION IN INDIA FROM A WESTERN PERSPECTIVE. Thirumurthi, Selvi; Graham, David Y. // Indian Journal of Medical Sciences;Sep2010, Vol. 64 Issue 9, p423 

    Helicobacter pylori is a common bacterial infectious disease whose manifestations predominately affect the gastrointestinal tract. India is the prototypical developing country as far as H. pylori infection is concerned and more than 20 million Indians are estimated to suffer from peptic ulcer...

  • Evaluation of Epigastric Discomfort and Management of Dyspepsia and GERD. Schroeder, Barrett M. // American Family Physician;9/15/2003, Vol. 68 Issue 6, p1215 

    Focuses on the guideline issued by the Institute for Clinical Systems Improvement in September 2003 on the evaluation and management of dyspepsia and gastroesophageal reflux disease (GERD). Procedure of choice for the evaluation of dyspepsia; Recommendation if Helicobacter pylori testing is...

  • Clinical gastroenterology. Forgacs, Ian // BMJ: British Medical Journal (International Edition);1/14/95, Vol. 310 Issue 6972, p113 

    Discusses the key aspects of progress in gastrointestinal disease. Helicobacter pylori; Inflammatory bowel disease; Gastrointestinal cancer.

  • Treatment of functional dyspepsia: where to go and what to do. Oshima, Tadayuki; Miwa, Hiroto // Journal of Gastroenterology;Jul2006, Vol. 41 Issue 7, p718 

    The article discusses a research on the treatment of functional dyspepsia. In reference to a study by T.L. Ang and colleagues in this same issue. It found that Helicobacter pylori eradication and prokinetic therapy resulted in symptom improvement in more than 60 percent of functional dyspepsia...

  • Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1β-511 polymorphisms are independent risk factors for gastric cancer in Thais. Yamada, Sirikan; Matsuhisa, Takeshi; Makonkawkeyoon, Luksana; Chaidatch, Suparp; Kato, Shunji; Matsukura, Norio // Journal of Gastroenterology;Dec2006, Vol. 41 Issue 12, p1169 

    Thailand has the lowest incidence of gastric cancer in the world. Helicobacter pylori infection, a low serum pepsinogen I/II ratio, and interleukin (IL)-1β-511 polymorphisms are suspected to be risk factors for gastric cancer. A total of 167 Thais, comprising 56 cancer patients and 111...

  • Effect of Treatment of Helicobacter pylori Infection on the Long-Term Recurrence of Gastric or Duodenal Ulcer. Graham, David Y.; Lew, Ginger M.; Klein, Peter D.; Evans, Dolores G.; Evans Jr., Doyle J.; Saeed, Zahid A.; Malaty, Hoda M. // Annals of Internal Medicine;5/1/92, Vol. 116 Issue 9, p705 

    Focuses on a study which determined the effect of treating Helicobacter pylori infection on the recurrence of gastric and duodenal ulcer disease from September 1988 to October 1990. Research design and setting; Characteristics of participating patients; Details of intervention; Measurements and...

  • Symptomatic Benefit from Eradicating. McColl, Kenneth; Murray, Lilian; El-Omar, Emad; Dickson, Anthea; El-Nujumi, Adil; Wirz, Angela; Kelman, Andrew; Penny, Christine; Knill-Jones, Robin; Hilditch, Thomas // New England Journal of Medicine;12/24/98, Vol. 339 Issue 26, p1869 

    Background: The eradication of Helicobacter pylori infection is beneficial in patients with gastric or duodenal ulcers. The value of eradicating the infection in patients with dyspepsia and no evidence of ulcer disease is not known. Methods: We performed a randomized, placebo-controlled trial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics